Tuberculosis (TB) remains a significant global health challenge, necessitating improved diagnostic methods for effective control and eradication. This article presents a comprehensive review of the contemporary diagnostic approaches for TB in healthcare settings.
Advancements in molecular biology have led to the development of rapid, sensitive and specific diagnostic tools for TB. Techniques such as Polymerase Chain Reaction (PCR) and Whole Genome Sequencing (WGS) have revolutionized TB diagnostics, facilitating early detection and precise identification of drug-resistant strains.
Imaging techniques like Chest X-rays and Computed Tomography (CT) scans remain integral in TB diagnostics, providing visual evidence of pulmonary abnormalities. However, these techniques are less effective in detecting extrapulmonary TB and in patients co-infected with HIV.
Immunological tests such as the Tuberculin Skin Test (TST) and the Interferon Gamma Release Assays (IGRAs) are widely used for TB diagnosis. While TST is simple and inexpensive, it has limitations in specificity and sensitivity. IGRAs, on the other hand, offer better specificity but are more expensive and require sophisticated laboratory infrastructure.
Microbiological techniques like sputum smear microscopy and culture remain the gold standard for TB diagnosis. However, these methods are time-consuming and have reduced sensitivity in patients with paucibacillary disease or children.
While significant advancements have been made in TB diagnostics, no single technique is universally applicable due to variations in sensitivity, specificity, cost, and infrastructural requirements. An effective diagnostic approach should, therefore, incorporate a combination of these techniques tailored to the specific needs of the patient population and healthcare setting. Continued research and innovation are imperative to unmask TB and curb its global impact.
1.
Researchers found that patients undergoing chemotherapy had a higher risk of mixed infections and should begin antibiotic therapy right away.
2.
Study confirms safety and efficacy of higher-dose-per-day radiation for early-stage prostate cancer
3.
Admissions, medical schools, costs, and eligibility requirements information for FNB Onco-Anesthesia.
4.
Radiation therapy can promote amphiregulin, which increases growth of metastases
5.
High Success Rate With Conversion Therapy for Unresectable Gastroesophageal Cancer
1.
Learning from Uncommon Inherited Bleeding Disorder Presentations
2.
Essential Strategies in Hematology for Healthcare Excellence
3.
An Overview Of Leukemia Cutis: What It Is And How To Treat It
4.
All About Ferric Gluconate – The Best Source Of Iron For Anemia
5.
Lymphomatoid Papulosis: What You Need to Know
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Beyond the Mutation: Addressing the Unmet Needs in ALK-Positive NSCLC
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI
3.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV
4.
Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial
5.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part I
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation